CAJ | 학술논문

目的通过与经尿道2μm激光前列腺剜除术相比较,评估经尿道2μm激光前列腺剥离术治疗前列腺增生的疗效和安全性。方法随机采用经尿道2μm激光前列腺剥离术或经尿道2μm激光前列腺剜除术治疗168例前列腺增生患者,比较两种手术方式的相关临床指标。结果术前两组患者一般情况比较差异无统计学意义(P>0.05)。剥离术组切除前列腺(19.96±13.57)g,剜除术组切除前列腺(17.04±11.8)g；剥离术组的手术时间(100.7±27.8)min 略大于剜除术组(97.89±40.3)min(P=0.101)；剥离术组的术中出血量(10.8±7.42)ml 小于剜除术组(22.73±10.9)ml,两组间比较差异有统计学意义(P<0.05)；国际前列腺症状评分、生活质量评分及最大尿流率术后均有明显改善(P<0.01)。结论经尿道2μm激光前列腺剥离术与经尿道2μm 激光前列腺剜除术相比,有相同的近期疗效,具有良好的止血效果,而且操作较容易,更利于推广实施,能显著降低手术风险,是治疗前列腺增生的一种新的安全、有效的微创手术方式。
목적통과여경뇨도2μm격광전렬선완제술상비교,평고경뇨도2μm격광전렬선박리술치료전렬선증생적료효화안전성。방법수궤채용경뇨도2μm격광전렬선박리술혹경뇨도2μm격광전렬선완제술치료168례전렬선증생환자,비교량충수술방식적상관림상지표。결과술전량조환자일반정황비교차이무통계학의의(P>0.05)。박리술조절제전렬선(19.96±13.57)g,완제술조절제전렬선(17.04±11.8)g；박리술조적수술시간(100.7±27.8)min 략대우완제술조(97.89±40.3)min(P=0.101)；박리술조적술중출혈량(10.8±7.42)ml 소우완제술조(22.73±10.9)ml,량조간비교차이유통계학의의(P<0.05)；국제전렬선증상평분、생활질량평분급최대뇨류솔술후균유명현개선(P<0.01)。결론경뇨도2μm격광전렬선박리술여경뇨도2μm 격광전렬선완제술상비,유상동적근기료효,구유량호적지혈효과,이차조작교용역,경리우추엄실시,능현저강저수술풍험,시치료전렬선증생적일충신적안전、유효적미창수술방식。
Objective To compare the treatment effects of transurethral prostate decollement and enucleation with 2μm laser for benign prostatic hyperplasia (BPH). Methods One hundred and sixty-eight cases of BPH were divided into two groups randomly and underwent transurethral prostate decollement or enucleation with 2μm laser .In decollement technology group,the mean age of patients was (72.95±5.56)years,and mean prostatic volume was (59.93±20.9)ml.In enucleation technology group,the mean age of patients was (74.02±3.32)years,and mean prostatic volume was (57.82±28.17)ml.The significant markers and therapeutic results were analyzed. Results There was no significant difference between the two groups in preoperative clinical factors (P>0.05).No tran-surethral decollement syndrome was observed,and no blood transfusions were needed during opera-tion.The operation time of decollement technology group (97.89±40.3)min was not significant shorter than that in enucleation technology group with 2μm laser (100.7±27.8)(P=0.101).There were significant differences for blood loss during operation between decollement technology group (22.73±10.9)ml and enucleation technology group (10.8±7.42)ml (P<0.01).The IPSS,QOL and Qmax were improved significantly after operation in both groups (P<0.05),but no significant differences had been noted with different procedure (P>0.05). Conclusions The transurethral prostate decollement with 2μm laser has the same early efficacy as well as the transurethral prostate enucleation with 2 μm laser,and has the same blood loss.The transurethral prostate decollement with 2μm laser is a safe and effective minimally invasive treatment for BPH.